Cargando…
Serum Biomarkers for the Prediction of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a leading cause of global cancer death. Major etiologies of HCC relate to chronic viral infections as well as metabolic conditions. The survival rate of people with HCC is very low and has been attributed to late diagnosis with limited treatment options. Combining u...
Autores principales: | Debes, José D., Romagnoli, Pablo A., Prieto, Jhon, Arrese, Marco, Mattos, Angelo Z., Boonstra, André |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038187/ https://www.ncbi.nlm.nih.gov/pubmed/33918270 http://dx.doi.org/10.3390/cancers13071681 |
Ejemplares similares
-
Assessment of STAT4 Variants and Risk of Hepatocellular Carcinoma in Latin Americans and Europeans
por: Ayoub, Alan, et al.
Publicado: (2023) -
MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort
por: Goble, Spencer, et al.
Publicado: (2023) -
Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy
por: Mattos, Ângelo Z, et al.
Publicado: (2021) -
Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
por: Mattos, Ângelo Z, et al.
Publicado: (2021) -
Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?
por: Mattos, Ângelo Z, et al.
Publicado: (2022)